» Articles » PMID: 26932552

Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date

Overview
Journal CNS Drugs
Specialties Neurology
Pharmacology
Date 2016 Mar 3
PMID 26932552
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

The neuropeptide oxytocin plays a role in reward, stress, social affiliation, learning, and memory processes. As such, there is increasing interest in oxytocin as a potential treatment for addictions. The endogenous oxytocin system is itself altered by short- or long-term exposure to drugs of abuse. A large number of preclinical studies in rodents have investigated the effect of oxytocin administration on various drug-induced behaviors to determine whether oxytocin can reverse the neuroadaptations occurring with repeated drug and alcohol use. In addition, the mechanisms by which oxytocin acts to modify the behavioral response to drugs of abuse are beginning to be understood. More recently, a few small clinical studies have been conducted in cocaine, cannabis, and alcohol dependence. This review summarizes the preclinical as well as clinical literature to date on the oxytocin system and its relevance to drug and alcohol addiction.

Citing Articles

Oxytocin Reduces Methylphenidate-Induced Dorsal Striatal Dopamine Release in Male Rhesus Macaques.

Lee M, Shokri Kojori E, Dieckmann W, Singley E, Mattison J, Herscovitch P Int J Neuropsychopharmacol. 2024; 28(1).

PMID: 39626021 PMC: 11681423. DOI: 10.1093/ijnp/pyae056.


A positive affect intervention alters leukocyte DNA methylation in sexual minority men with HIV who use methamphetamine.

Carrico A, Cherenack E, Flentje A, Moskowitz J, Asam K, Ghanooni D Brain Behav Immun. 2024; 120:151-158.

PMID: 38777283 PMC: 11269022. DOI: 10.1016/j.bbi.2024.05.025.


Brain proteomic atlas of alcohol use disorder in adult males.

Teng P, Barakat W, Tran S, Tran Z, Bateman N, Conrads K Transl Psychiatry. 2023; 13(1):318.

PMID: 37833300 PMC: 10575941. DOI: 10.1038/s41398-023-02605-0.


Alcohol does not influence trust in others or oxytocin, but increases positive affect and risk-taking: a randomized, controlled, within-subject trial.

Wenger L, Hamm O, Muhle C, Hoffmann S, Reinhard I, Bach P Eur Arch Psychiatry Clin Neurosci. 2023; 274(2):311-320.

PMID: 37707566 PMC: 10914917. DOI: 10.1007/s00406-023-01676-w.


Structure-Based Design of Glycosylated Oxytocin Analogues with Improved Selectivity and Antinociceptive Activity.

Szabo L, Tanguturi P, Goodman H, Sprober S, Liu C, Al-Obeidi F ACS Med Chem Lett. 2023; 14(2):163-170.

PMID: 36793431 PMC: 9923833. DOI: 10.1021/acsmedchemlett.2c00455.


References
1.
Qi J, Yang J, Song M, Li Y, Wang F, Wu C . Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice. Naunyn Schmiedebergs Arch Pharmacol. 2007; 376(6):441-8. DOI: 10.1007/s00210-007-0245-8. View

2.
Manning M, Stoev S, Chini B, Durroux T, Mouillac B, Guillon G . Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Prog Brain Res. 2008; 170:473-512. DOI: 10.1016/S0079-6123(08)00437-8. View

3.
Hoge E, Pollack M, Kaufman R, Zak P, Simon N . Oxytocin levels in social anxiety disorder. CNS Neurosci Ther. 2008; 14(3):165-70. PMC: 6494012. DOI: 10.1111/j.1755-5949.2008.00051.x. View

4.
Yoshida M, Takayanagi Y, Inoue K, Kimura T, Young L, Onaka T . Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice. J Neurosci. 2009; 29(7):2259-71. PMC: 6666325. DOI: 10.1523/JNEUROSCI.5593-08.2009. View

5.
Qi J, Yang J, Wang F, Zhao Y, Song M, Wu C . Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement. Neuropharmacology. 2009; 56(5):856-65. DOI: 10.1016/j.neuropharm.2009.01.010. View